In the United States, some coronavirus patients are allowed to be treated with a REGN-COV2 antibody "cocktail" developed by President Donald Trump's biotechnology company Regeneron Pharmaceuticals.According to Gadin.Net, this was reported by RIA Novosti.According to the US Food and Drug Administration (FDA), the drug will be used only in emergencies in patients with mild to moderate disease.This "cocktail" will not be used for oxygen therapy or for those who are seriously ill.